close

Clinical Trials

1 205 206 207 208 209 220
Number of results: 4389

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-11-22 PXT-3003 (fixed-dose combination of (R-S) baclofen, naltrexone hydrochloride and D-sorbitol) Charcot-Marie-Tooth disease 2 Pharnext (France) Rare diseases - Genetic diseases - Neurological diseases
2011-11-19 Enzyme Replacement Therapy (ERT) Pompe disease and other metabolic disorders UGent and Vrije Universiteit (Belgium) Oxyrane (Belgium-UK-USA) Genetic diseases - Rare diseases - Metabolic diseases
2011-11-16 albiglutide type 2 diabetes 3 GSK (UK) Metabolic diseases
2011-11-15 Fibrocaps™ 2 ProFibrix (The Netherlands) Hemostasis
2011-11-13 Xarelto® (rivaroxaban)

Secondary Prevention of Acute Coronary Syndrome (ACS)

3 Bayer HealthCare (Germany) Cardiovascular diseases
2011-11-12 Certican® (everolimus)

liver transplantation

3 Novartis (Switzerland) Transplantation
2011-11-10 REGN727/SAR236553
elevated low-density lipoprotein cholesterol
2 Sanofi (France) Regeneron Pharmaceuticals (USA) Cardiovascular diseases - Metabolic diseases
2011-11-10 ALX-0081

Acute coronary syndrome (ACS)

2 Ablynx (Belgium) Cardiovascular diseases
2011-11-10 RPL554 chronic obstructive pulmonary disease (COPD) 2a Verona Pharma (UK) Respiratory diseases
2011-11-09 ND0611 Dermal Patch Parkinson's disease 1-2 NeuroDerm (Israel) Neurodegenerative diseases - CNS diseases
2011-11-08 BI 201335 chronic hepatitis C 2b Boehringer Ingelheim (Germany) Infectious diseases
2011-11-08 CYT107 (Recombinant human interleukin-7) hepatitis C

 

1-2a Cytheris (France) Infectious diseases
2011-11-08 CV301 2 Bavarian Nordic (Denmark) Cancer Oncology
2011-11-07 BI 201335 chronic hepatitis C 2b Boehringer Ingelheim (Germany) Infectious diseases
2011-11-07 eltrombopag

hepatitis C virus related thrombocytopenia

3 GSK (UK) Infectious diseases
2011-11-07 Vidofludimus

rheumatoid arthritis

2b 4SC (Germany) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2011-11-07 simeprevir (TMC435) 2b Tibotec Pharmaceuticals-J&J (Ireland - USA) Medivir (Sweden) Infectious diseases
2011-11-07 CV9201 non small cell lung cancer (NSLC)
1-2a CureVac (Germany) Cancer - Oncology
2011-11-07 DegludecPlus

type 2 diabetes

3a Novo Nordisk (Denmark) Metabolic diseases
2011-11-07 ACZ885 (canakimumab)

systemic juvenile idiopathic arthritis (SJIA)

3 Novartis (Switzerland) Autoimmune diseases - Rare diseases